Cargando…
Biomarkers for Alzheimer’s Disease Early Diagnosis
Alzheimer’s disease (AD) is the most common cause of dementia, affecting the central nervous system (CNS) through the accumulation of intraneuronal neurofibrillary tau tangles (NFTs) and β-amyloid plaques. By the time AD is clinically diagnosed, neuronal loss has already occurred in many brain and r...
Autores principales: | Ausó, Eva, Gómez-Vicente, Violeta, Esquiva, Gema |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7563965/ https://www.ncbi.nlm.nih.gov/pubmed/32899797 http://dx.doi.org/10.3390/jpm10030114 |
Ejemplares similares
-
Visual Side Effects Linked to Sildenafil Consumption: An Update
por: Ausó, Eva, et al.
Publicado: (2021) -
MicroRNAs in the Mouse Developing Retina
por: Navarro-Calvo, Jorge, et al.
Publicado: (2023) -
Epigenetic Peripheral Biomarkers for Early Diagnosis of Alzheimer’s Disease
por: Villa, Chiara, et al.
Publicado: (2022) -
Biomarkers for early diagnosis of Alzheimer disease: ‘ALZheimer ASsociated gene’– a new blood biomarker?
por: Jellinger, Kurt A, et al.
Publicado: (2008) -
Cerebrospinal Fluid Biomarkers for Early and Differential Alzheimer’s Disease Diagnosis
por: Bjerke, Maria, et al.
Publicado: (2018)